Hepatitis C Trial, Recruiting (NCT07095192)

Hepatitis C Trial, Recruiting NCT07095192 Sponsor: McGill University Condition: Hepatitis C

Printed from Voxsanity (voxsanity.com.au) — NCT07095192 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hepatitis C

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older and have a risk of getting Hepatitis C (HCV), or you visit a service that supports people at risk of Hepatitis C
You work at a site that provides Hepatitis C services, either delivering those services directly or supervising others who do
You work in local, regional, or national government or a health authority in a role that influences Hepatitis C testing or treatment policies, and you can share insights into planning and funding for Hepatitis C care
You work in a laboratory, quality assurance, or regulatory role overseeing point-of-care testing (tests done on-site rather than sent to a lab) at a regional, national, or organisational level

Who may not be able to join:

Anyone under 18 years old

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Guillaume Fontaine, RN, PhD, McGill University

Phone: 514-994-9298

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07095192

Sponsor: McGill University

Phase: Not Applicable

Status: Recruiting

Condition: Hepatitis C

Trial contact: 514-994-9298

More information: https://clinicaltrials.gov/study/NCT07095192

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older and have a risk of getting Hepatitis C (HCV), or you visit a service that supports people at risk of Hepatitis C
You work at a site that provides Hepatitis C services, either delivering those services directly or supervising others who do
You work in local, regional, or national government or a health authority in a role that influences Hepatitis C testing or treatment policies, and you can share insights into planning and funding for Hepatitis C care
You work in a laboratory, quality assurance, or regulatory role overseeing point-of-care testing (tests done on-site rather than sent to a lab) at a regional, national, or organisational level

Who may not be able to join:

Anyone under 18 years old

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

McGill University

Registry

ClinicalTrials.gov

Start date

20 May 2025

Est. completion

20 June 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Measure Barriers and facilitators based on the CFIR Constructs; Acceptability and Feasibility of Point-of-Care Testing Strategies (Provider/Manager Survey, Section 2); Acceptability and Feasibility of Point-of-Care Testing Strategies (Provider/Manager Survey, Section 3); Sustainability of Point-of-Care Testing Strategies using the Time-driven activity-based costing (TDABC)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov